Godsey & Gibb Inc’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.2K Hold
455
﹤0.01% 216
2026
Q1
$27.6K Sell
455
-65
-13% -$3.79K ﹤0.01% 212
2025
Q4
$28K Buy
520
+65
+14% +$3.13K ﹤0.01% 212
2025
Q3
$20.5K Hold
455
﹤0.01% 223
2025
Q2
$21.1K Hold
455
﹤0.01% 213
2025
Q1
$27.8K Hold
455
﹤0.01% 205
2024
Q4
$25.7K Hold
455
﹤0.01% 208
2024
Q3
$23.5K Sell
455
-1,179
-72% -$55.3K ﹤0.01% 243
2024
Q2
$67.8K Buy
1,634
+1,509
+1,207% +$67.5K 0.01% 168
2024
Q1
$6.78K Sell
125
-300
-71% -$15.3K ﹤0.01% 301
2023
Q4
$21.8K Sell
425
-300
-41% -$15.7K ﹤0.01% 215
2023
Q3
$42.1K Hold
725
0.01% 170
2023
Q2
$46.4K Hold
725
0.01% 173
2023
Q1
$50.3K Hold
725
0.01% 164
2022
Q4
$52.2K Buy
+725
New +$54.7K 0.01% 117
2021
Q1
Sell
-3,592
Closed -$223K 104
2020
Q4
$223K Buy
+3,592
New +$221K 0.03% 93
2020
Q3
Sell
-5,550
Closed -$326K 82
2020
Q2
$326K Buy
5,550
+1,350
+32% +$80.7K 0.05% 69
2020
Q1
$234K Buy
4,200
+300
+8% +$18.3K 0.04% 75
2019
Q4
$250K Sell
3,900
-150
-4% -$8.59K 0.04% 84
2019
Q3
$205K Sell
4,050
-712
-15% -$33.5K 0.03% 87
2019
Q2
$216K Buy
+4,762
New +$222K 0.03% 84

Other funds holding BMY

Godsey & Gibb Inc's BMY Position: Q2 2026 in Review

Godsey & Gibb Inc held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 455 shares worth $26.2K. The position accounts for ﹤0.01% of the portfolio, ranked #216.

Godsey & Gibb Inc first reported a position in BMY in Q2 2019 and has held it in 21 quarters since. The position peaked at $326K in Q2 2020. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Godsey & Gibb Inc held 455 shares of Bristol-Myers Squibb worth $26.2K as of Q2 2026.
  • Godsey & Gibb Inc left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of Godsey & Gibb Inc's portfolio in Q2 2026, its #216 holding.
  • Godsey & Gibb Inc first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 21 quarters since.
  • Godsey & Gibb Inc's Bristol-Myers Squibb position peaked at $326K in Q2 2020.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Godsey & Gibb Inc's 13F filing for Q2 2026, filed 13 Jul 2026.